3-38723544-C-T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_006514.4(SCN10A):c.3238G>A(p.Asp1080Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000064 in 1,594,682 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006514.4 missense
Scores
Clinical Significance
Conservation
Publications
- sodium channelopathy-related small fiber neuropathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- episodic pain syndrome, familial, 2Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
- Brugada syndromeInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SCN10A | ENST00000449082.3 | c.3238G>A | p.Asp1080Asn | missense_variant | Exon 19 of 28 | 1 | NM_006514.4 | ENSP00000390600.2 | ||
| SCN10A | ENST00000643924.1 | c.3235G>A | p.Asp1079Asn | missense_variant | Exon 18 of 27 | ENSP00000495595.1 | ||||
| SCN10A | ENST00000655275.1 | c.3262G>A | p.Asp1088Asn | missense_variant | Exon 19 of 28 | ENSP00000499510.1 | 
Frequencies
GnomAD3 genomes  0.0000854  AC: 13AN: 152194Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.000286  AC: 60AN: 209960 AF XY:  0.000159   show subpopulations 
GnomAD4 exome  AF:  0.0000617  AC: 89AN: 1442370Hom.:  0  Cov.: 32 AF XY:  0.0000447  AC XY: 32AN XY: 716006 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000854  AC: 13AN: 152312Hom.:  0  Cov.: 33 AF XY:  0.0000537  AC XY: 4AN XY: 74498 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Episodic pain syndrome, familial, 2    Uncertain:1 
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
not specified    Benign:1 
Variant summary: SCN10A c.3238G>A (p.Asp1080Asn) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00029 in 209960 control chromosomes, predominantly at a frequency of 0.002 within the Latino subpopulation in the gnomAD database. The observed variant frequency within Latino control individuals in the gnomAD database exceeds the estimated maximal expected allele frequency for a pathogenic variant in SCN10A causing familial episodic pain syndrome, 2 phenotype. c.3238G>A has been reported in the literature in an individual affected with Brugada syndrome, without strong evidence for causality (Hu_2014). This report does not provide unequivocal conclusions about association of the variant with familial episodic pain syndrome or other SCN10A-related disorders. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 24998131). ClinVar contains an entry for this variant (Variation ID: 463247). Based on the evidence outlined above, the variant was classified as likely benign. -
Brugada syndrome    Benign:1 
- -
not provided    Benign:1 
This variant is associated with the following publications: (PMID: 24998131, 30821013, 28407228) -
Cardiovascular phenotype    Benign:1 
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at